Product Name: Losmapimod
Chemical Name: 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
SMILES Code: O=C(C1=CC=C(C2=CC(C(NC3CC3)=O)=CC(F)=C2C)N=C1)NCC(C)(C)C
CAS NO: 203935-39-1 Product: Skp2 Inhibitor C1
Synonym: GSK-AHAB; GW856553X; SB856553; GW 856553X; SB 856553; GW-856553X; SB-856553
Chemical Formula: C22H26FN3O2
Appearance: Solid powderWeb Site：Medchemexpress
Purity: 98% (this data is for the first batch)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 8211; 4 C for short term (days to weeks) or -20 C for long term (months to years).COMT inhibitors
Solubility: Soluble in DMSO, not in water
Background Description: Losmapimod (GW856553X; SB856553; GSK-AHAB) is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively. Losmapimod has completed Phase II human clinical trials for the treatment of depression althouPubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19401447
Related Posts
Product Name: Losmapimod
Chemical Name: 6-[5-(cyclopropylcarbamoyl)-3-fluoro-2-methylphenyl]-N-(2,2-dimethylpropyl)pyridine-3-carboxamide
SMILES Code: O=C(C1=CC=C(C2=CC(C(NC3CC3)=O)=CC(F)=C2C)N=C1)NCC(C)(C)C
CAS NO: 203935-39-1 Product: Skp2 Inhibitor C1
Synonym: GSK-AHAB; GW856553X; SB856553; GW 856553X; SB 856553; GW-856553X; SB-856553
Chemical Formula: C22H26FN3O2
Appearance: Solid powderWeb Site：Medchemexpress
Purity: 98% (this data is for the first batch)
Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.
Storage Condition: Dry, dark and at 0 8211; 4 C for short term (days to weeks) or -20 C for long term (months to years).COMT inhibitors
Solubility: Soluble in DMSO, not in water
Background Description: Losmapimod (GW856553X; SB856553; GSK-AHAB) is a selective, potent, and orally active p38 MAPK inhibitor with pKi of 8.1 and 7.6 for p38α and p38β, respectively. Losmapimod has completed Phase II human clinical trials for the treatment of depression althouPubMed ID:http://www.ncbi.nlm.nih.gov/pubmed/19401447